Valérie Gounant

10PUBLICATIONS
96CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 06, 2025
Recurrent respiratory papillomatosis in adults with lower respiratory tract involvement: a retrospective study of the OrphaLung and GETIF networks.

Romy Ratsihorimanana, Thomas Maitre, Matthieu Dusselier

|Oct 22, 2024
Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates.

Filippo G Dall'Olio, Wael Zrafi, Veronique Roelants

|Oct 21, 2024
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.

Gary Birsen, Valérie Gounant, Nicolas Girard

|Aug 26, 2022
Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study.

Nadia Guezour, Ghassen Soussi, Solenn Brosseau

|Mar 10, 2022
Measuring Walking Speed Failed to Predict Early Death and Toxicity in Elderly Patients with Metastatic Non-Small-Cell Lung Cancer (NSCLC) Selected for Undergoing First-Line Systemic Treatment: An Observational Exploratory Study.

Amélie Aregui, Johan Pluvy, Manuel Sanchez

|Jan 27, 2022
Transthoracic lung biopsy for pulmonary nodules ≤20 mm in routine clinical care.

Emilie Lissavalid, Antoine Khalil, Ghassen Soussi

Pageof 2

Frequent Collaborators

3 joint publications

Ghassen Soussi

3 joint publications

Gérard Zalcman

3 joint publications

Raphael Borie

2 joint publications

Isabelle Monnet